Myriad Genetics (MYGN) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	86.9M
Marketable investment securities	61.5M
Prepaid expenses
Inventory, net	53.9M
Trade accounts receivable, less allowance for doubtful accounts of $3,700 in 2011 and $4,400 in 2010	98.2M
Deferred taxes
Other receivables
Total current assets	322.9M
Equipment
Leasehold improvements
Gross equipment and leasehold improvements
Less accumulated depreciation
Net equipment and leasehold improvements	56.8M
Long-term marketable investment securities	52.2M
Long-term deferred taxes
Intangibles, net	521.2M
Goodwill	312.8M
Total assets	1.27B
Accounts payable	19.9M
Accrued liabilities	54.8M
Deferred revenue	1M
Total current liabilities	274.9M
Unrecognized tax benefits	24.4M
Total liabilities	535.6M
Commitments and contingencies (Note 13)	0
Preferred stock, $0.01 par value, authorized 5,000 shares; no shares issued and outstanding
Common stock, $0.01 par value, authorized 150,000 shares; issued and outstanding 86,244 shares in 2011 and 94,046 shares in 2010	700K
Additional paid-in capital
Accumulated other comprehensive income	-5.6M
Accumulated deficit	-86.5M
Total stockholders' equity	735.5M
Total liabilities and stockholders' equity	1.27B

Entities mentioned with MYGN

View All Entities